These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 3701044)

  • 1. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.
    Anderson RM; Grenfell BT
    J Hyg (Lond); 1986 Apr; 96(2):305-33. PubMed ID: 3701044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes.
    Anderson RM; May RM
    J Hyg (Lond); 1985 Jun; 94(3):365-436. PubMed ID: 4008922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella vaccination in India: identifying broad consequences of vaccine introduction and key knowledge gaps.
    Winter AK; Pramanik S; Lessler J; Ferrari M; Grenfell BT; Metcalf CJE
    Epidemiol Infect; 2018 Jan; 146(1):65-77. PubMed ID: 29198212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
    Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C
    Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rubella antibody titers in vaccinated and nonvaccinated women and results of vaccination during pregnancy.
    Enders G
    Rev Infect Dis; 1985; 7 Suppl 1():S103-7. PubMed ID: 4001718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against rubella and measles: quantitative investigations of different policies.
    Anderson RM; May RM
    J Hyg (Lond); 1983 Apr; 90(2):259-325. PubMed ID: 6833747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubella epidemiology in South East England.
    Nokes DJ; Anderson RM; Anderson MJ
    J Hyg (Lond); 1986 Apr; 96(2):291-304. PubMed ID: 3701043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling rubella in Europe.
    Edmunds WJ; van de Heijden OG; Eerola M; Gay NJ
    Epidemiol Infect; 2000 Dec; 125(3):617-34. PubMed ID: 11218213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling.
    Wu Y; Wood J; Khandaker G; Waddington C; Snelling T
    Vaccine; 2016 Nov; 34(46):5636-5642. PubMed ID: 27670077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of congenital rubella syndrome. The role of maternal parity.
    Schoenbaum SC; Biano S; Mack T
    JAMA; 1975 Jul; 233(2):151-5. PubMed ID: 1173441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella--a reappraisal.
    Wynchank S; Barron J; Kipps A
    S Afr Med J; 1977 Dec; 52(24):953-6. PubMed ID: 609965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against rubella in Britain: benefits and risks.
    Freestone DS
    Dev Biol Stand; 1979; 43():339-48. PubMed ID: 520680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of congenital rubella syndrome after a community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000 to 2001.
    Lanzieri TM; Segatto TC; Siqueira MM; de Oliviera Santos EC; Jin L; Prevots DR
    Pediatr Infect Dis J; 2003 Apr; 22(4):323-9. PubMed ID: 12690271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of epidemiological peculiarities of rubella based on a mathematical model (according to observations over 10 years in Moscow).
    Kantorovich RA; Gol'dfarb LG; Volodina NI; Myskin AA
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):43-50. PubMed ID: 6854012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiological assessment towards elimination of rubella and congenital rubella syndrome in Singapore.
    Chua YX; Ang LW; Low C; James L; Cutter JL; Goh KT
    Vaccine; 2015 Jun; 33(27):3150-7. PubMed ID: 25887085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the incidence of congenital rubella syndrome in developing countries.
    Cutts FT; Vynnycky E
    Int J Epidemiol; 1999 Dec; 28(6):1176-84. PubMed ID: 10661666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balancing evidence and uncertainty when considering rubella vaccine introduction.
    Lessler J; Metcalf CJ
    PLoS One; 2013; 8(7):e67639. PubMed ID: 23861777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.